SCYNEXIS Inc. appointed Marion McCourt as a board member.
McCourt was most recently COO of biopharmaceutical company Medivation Inc. until it was acquired by Pfizer Inc. in September 2016. Her appointment expands SCYNEXIS' board to eight members.
SCYNEXIS appoints director
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
SCYNEXIS Inc. appointed Marion McCourt as a board member.
McCourt was most recently COO of biopharmaceutical company Medivation Inc. until it was acquired by Pfizer Inc. in September 2016. Her appointment expands SCYNEXIS' board to eight members.